EUVIMED · CrossrefZeitschrift
European Heart Journal – Cardio-Oncology
ISSN 2755-6646 · Oxford University Press (OUP)
Neueste Artikel
Launching European Heart Journal – Cardio-Oncology : defining the next era of cardiovascular care across the cancer continuum
Risk of non-fatal MACE in patients treated with zanubrutinib and acalabrutinib: a propensity-matched analysis
Cardiovascular Risk of First and Second Generation Bruton’s Tyrosine Kinase Inhibitors: A Systematic Review and Network Meta-Analysis
The use of natriuretic peptide to screen for stage B heart failure based on echocardiogram among cancer survivors
Coronary Plaque Burden and Plaque Composition in Long-Term Cancer Survivors: A Comparative CCTA Study
Statin Use in CHIP–ASCVD Research: Bias, Biology, or Both?
Rationale, Study Design and Challenges from the SOCRATES Study
Deploying Meaningful Medical Informatics and Artificial Intelligence Solutions in the Clinical Field: A Call to Action for Researchers in Cardio-Oncology Informatics
Cardiovascular toxicity of BTK inhibitors: comparing what can be compared
Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors
Cancer therapy-related cardiovascular toxicity testing: an overview of experimental preclinical in vitro models and how to best use them in combination with animal models, omics and AI-based in silico approaches
Answer to the letter “Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors” from Hasan Burak Isleyen and Zehra Sucuoglu
EUVIMED